Thomas Gastinne

机构：Centre Hospitalier Universitaire de Nantes, Laboratoire de Thermique et Energie de Nantes, Centre d'Investigation Clinique de Nantes, Nantes Université · ORCID：0000-0003-4704-1187

发表论文 323 篇 · 总被引 7844 次 · h-index 41

代表论文

• Preemptive Immunoglobulin Prophylaxis Reduces Infections in Patients Treated With Anti-BCMA Bispecific Antibodies (2025 · Clinical Lymphoma Myeloma & Leukemia · 被引 3)
• Pirtobrutinib in Relapsed/Refractory (R/R) Waldenström macroglobulinemia (WM): Up to 5 years of follow-up from the Phase 1/2 BRUIN study (2025 · Blood · 被引 2)
• Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial (2026 · The Lancet Haematology · 被引 1)
• Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis (2026 · Blood · 被引 1)
• Results of the primary end-point of the LOC-R01: A randomized phase II Study of lenalidomide and ibrutinib in association with rituximab-methotrexate procarbazine vincristin (R-MPV) as a targeted induction treatment for patients aged 18 to 65 with a newly diagnosed primary central nervous system lymphoma (PCNSL) (2025 · Blood · 被引 1)
• Outcomes and treatment patterns of patients with primary mediastinal b-cell lymphoma after CAR-t cell therapy failure : A descar-t analysis (2025 · Blood · 被引 1)